BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News (World)
Pluristem Life Systems Inc. Granted European Patent For Use Of Cells To Help Treat Damaged Bone Marrow 5/6/2015
Amarantus BioSciences, Inc. Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use For MANF 5/5/2015
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug 'Stempeucel' 4/27/2015
GW Pharmaceuticals (GWPH) Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy 4/27/2015
Forward Pharma (FWP) Receives Decision To Grant From EPO For DMF Patent In Europe 4/27/2015
Probiodrug AG Release: Key Patents On Glutaminyl Cyclase (QC) Inhibition For The Treatment Of Alzheimer’s Disease Granted In Japan 4/23/2015
ERYtech Pharma Strengthens Its Intellectual Property Position In The U.S. 4/21/2015
Emotional Brain Obtains Patent Extension For Its Female Sexual Dysfunction Medication 4/17/2015
AEterna Zentaris (AEZS) Files Additional Patent Application To Strengthen IP Protection Of Zoptarelin Doxorubicin 4/16/2015
RedHill Biopharma Ltd. (RDHL) Receives Notice Of Allowance For Additional U.S. Patent For RHB-105 H. Pylori Bacterial Infection Treatment 4/16/2015
Mylan (MYL) Settles Patent Litigation Related To Viagra 4/14/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering TCR-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/8/2015
USPTO Issues Key US Patent To TiGenix For The Use Of Adipose-Derived Stromal Cells In The Treatment Of Fistulas 4/8/2015
Resverlogix Corporation (RVX.TO) Receives Two Patents For RVX-208 In China 4/7/2015
Cardio3 BioSciences Receives USPTO Notice Of Allowance For First U.S. Patent Broadly Covering Tcr-Deficient T-Cells Engineered To Express A Chimeric Antigen Receptor 4/7/2015
Kamada Ltd. (KMDA) Receives Allowance For Key Canadian Patent For Large Scale Production And Use Of Proprietary Alpha-1 Proteinase Inhibitor 4/1/2015
Mesoblast Limited (MSB.AX) Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 3/27/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent Acceptance Notice For The Use Of TB4 To Prevent Tissue Damage Associated With Heart Attack And Stroke Treatments 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Grant Of EU Patent For MOB-015 Related To Topical Treatment Of Onychomycosis (Nail Fungus) 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent For Kerasal Nail 3/25/2015
Enzymotec Reports A Decision Of The U.S. Patent And Trademark Office 3/24/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents For Their NCEs In Canada, Japan And Korea 3/24/2015
ISA Pharmaceuticals Granted European Patent For The Intradermal Administration Of ISA101 3/24/2015
Suven Life Sciences Ltd Secures 2 (Two) Product Patents For Their NCE’s Through New Mechanism Of Action - H3 Inverse Agonist In USA & New Zealand 3/16/2015
Enzymotec Granted New Patents In The United States And Australia Relevant To Phospholipid-Based Products 3/13/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Eurasia And Israel 3/9/2015
European Patent To Strengthen MediGene AG (MDGEF.PK)'s Dendritic Cell (DC) Vaccines Program 3/5/2015
CSIRO Maintains Foundational Patent For RNAi Gene Silencing Technology After European Opposition 3/2/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treating And Repairing Heart Damage 2/25/2015
XstalBio: US Patent Issued For Stabilization Of Therapeutic Proteins 2/25/2015
iBio, Inc. (IBIO) Adds Anthrax Antibodies To Product Pipeline 2/25/2015
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO Covering Cabaletta For The Treatment Of OPMD 2/24/2015
Opsona Therapeutics Ltd. Patent Issued In USA Covering An Antibody Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/23/2015
Opsona Therapeutics Ltd. Patent Issued In US And EU Covering The Opsona-Developed Antibody OPN-305, Which Is Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/20/2015
Orexo AB (ORXOF) Broadens ZUBSOLV Product Range and Announces Newly Listed Granted U.S. Patent 2/17/2015
Rosetta Genomics Ltd. (ROSG) Announces Key Patent Allowances In U.S. And Europe 2/17/2015
Suven Life Sciences Ltd Secures 4 (Four) Product Patents For Their NCE’s Through New Mechanism Of Action – H3 Inverse Agonist In Australia, Canada, Japan And New Zealand 2/16/2015
New Reverdia Patents Strengthen Biosuccinium™ Licensing 2/12/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent Related To MOB-015 For The Treatment Of Onychomycosis 2/11/2015
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015
Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating To NEXAVAR 2/9/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
Enzymotec Announces Favorable Response From The Australian Patent Office 2/3/2015
Provectus Biopharmaceuticals Inc.’ Novel Synthesis Patent Application Allowed By Chinese Patent Office 1/26/2015
Ablynx (ABLYF) Successfully Opposes Patent Appeal Case By Domantis Limited (GlaxoSmithKline (GSK)) 1/22/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Australia & Hong Kong, Two (2) Product Patents From Japan 1/20/2015
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Israel For Oral Administration Of GLP-1 1/16/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents And Multiple Myeloma Therapeutics" With Dr. Xiang-Qun (Sean) Xie, Professor Of Pharmaceutical Sciences At University of Pittsburgh 1/12/2015
Helsinn Healthcare SA Reaches Settlement Agreement Regarding Patent Dispute On ALOXI® 1/12/2015
Pluristem Therapeutics (PSTI) Granted Patent For Foundational Cell Harvesting Technology In South Africa 1/6/2015
Cellectis (ALCLS) Announces The Issuance By The USPTO Of A Patent Covering A Seminal Nuclease-Based “Gene Editing” Method 1/6/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Eurasia, Japan, And Mexico 12/30/2014
TWi Biotech Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In China 12/22/2014
BioBlast Pharma (ORPN) Receives Notice Of Patent Issuance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 12/17/2014
Suven Life Sciences Ltd Secures (5) Product Patents For Their Nces In Israel, Japan, China And New Zealand 12/12/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide 11/25/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014
Forward Pharma (FWP) Receives Issue Notification For Erosion Matrix Patent In The U.S. 11/24/2014
Ebola Vaccine Running Into Patent Cover In Canada? 11/21/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Two New U.S. Patents Relating To Topical Tetracycline Compositions 11/13/2014
Pluristem Therapeutics (PSTI) Granted Patents In Australia And New Zealand For Use Of Placental Cells In The Treatment Of Multiple Indications 11/12/2014
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS) 10/30/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
Pharmalink AB Extends Patent Protection For Nefecon® Treatment For Renal Disease 10/27/2014
ERYtech Pharma Announces Granting Of New Patent In The United States 10/21/2014
Lpath, Inc. (LPTN) Granted Key European Patent Related To iSONEP And ASONEP Programs 10/20/2014
Largest Biotech IPO Yet Could Be Derailed By Forward Pharma (FWP), Biogen Idec (BIIB) Patent Fight 10/15/2014
Prima Biomed (PRR.AX) Announces Immutep S.A.'s IMP321 Patent Application Receives Australian Notice Of Allowance 10/14/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Improvement Patent For Neuvax® (nelipepimut-S) In Japan 10/14/2014
BTG plc (BTG.L) Reaches Settlement Regarding CroFab® Patent Litigation 10/10/2014
MediGene AG (MDGEF.PK) Receives Patent For TCR-Modified T Cell Immunotherapy In Australia 10/8/2014
Pluristem Therapeutics (PSTI) Wins Cell Therapy Patent Case In Europe; European Patent Office Confirms Validity Of Amended Claims 10/7/2014
CleveXel Pharma To License Two New Oncology Patents From SATT Sud Est 10/6/2014
U.S. Patent and Trademark Office Issues Can-Fite BioPharma (CFBI) Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/30/2014
Kymab Succeeds In Revoking Regeneron Pharmaceuticals, Inc. (REGN)’s European Patent 9/19/2014
Biostar Pharmaceuticals, Inc. (BSPM) Files A PRC Patent Application For Oleanolic Acid Injection, Its New Drug Product For Hepatitis B And Liver Cancer 9/18/2014
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014
BerGenBio AS Granted Platform Patent - Cellselect™ Platform Also Described In Peer-Reviewed Journal 9/8/2014
Can-Fite BioPharma (CFBI) Issued Japanese Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/5/2014
Suven Life Sciences Ltd Secures (3) Product Patents For Their NCEs In South Korea, China And Canada 9/3/2014
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Spain For Oral Administration Of Insulin 8/19/2014
EnGeneIC Pty Ltd Receives Patent From The USPTO For EDV™ Nanocell Technology 8/11/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 8/6/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
C4X Discovery Patent Granted In Japan 7/15/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
BioLight Announces Issuance Of U.S. Patent For The Long-Term Controlled-Release Drug-Delivery Insert Platform 7/2/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
TWi Biotechnology Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 In United States 6/26/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
Arjuna Natural Extracts Ltd Receives Two Japanese Patents For BCM- 95® 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014
TWi Pharmaceuticals, Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/23/2014
Foamix Announces The Issuance Of Five Additional U.S. Patents 4/21/2014
Drawbridge Pharmaceuticals Announces Successful Clinical Trial Results For Phaxan™ And Grant Of U.S. Patent 4/16/2014
Depomed, Inc. (DEPO) Announces Settlements With Two Gralise® ANDA Filers 4/14/2014
Critical Pharmaceuticals Limited Receives Notice Of Allowance From US Patent And Trademark Office For Intranasal Growth Hormone And Parathyroid Hormone Products 4/8/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014
Enzymotec Provides Update On Patent Litigation With Neptune Technologies & Bioressources Inc. 4/1/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their NCEs In U.S.A. 3/26/2014
Merck & Co., Inc. (MRK) HIV Drug Strategy Seen Shielding Patent 3/21/2014
Actavis (ACT) Announces Daytrana® Patent Challenge Settlement 3/20/2014
Settlement Between BioPorto And Phadia AB In Patent Case 3/3/2014
Fibrotech Is Granted U.S. And Canadian Patents For Its Anti-Fibrotic Compounds 3/3/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 2/25/2014
Can-Fite BioPharma (CFBI) Granted Patent On The Manufacturing Of CF101 In Japan 2/25/2014
ISA Pharmaceuticals Strengthens Patent Protection For Its Lead Product ISA101 2/24/2014
Scancell: Publication Of Moditope Patent 2/18/2014
Pluristem Therapeutics (PSTI) Receives Key 3D Cell Expansion Patent In Australia 2/18/2014
BioAlliance Pharma: Strengthening And Extension Of The Industrial Protection Of Livatag® Until 2031 2/18/2014
OvaScience (OVAS) Issued Two U.S. Patents Covering AUGMENT? Fertility Treatment 2/12/2014
Actavis (ACT) Confirms Generic Treanda® Patent Challenge 2/4/2014
Enzymotec Announces It Has Been Granted Patents For INFAT®'S Uses In Canada And The US 2/3/2014
Suven Life Sciences Ltd Product Patents For Their NCEs In Canada, China And India 1/31/2014
Microbix Biosystems Inc. (MBXBF) Wins VIRUSMAX® Patent Challenge In Europe 1/23/2014
Anergis Obtains Core Technology Patent In Japan 1/14/2014
Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio 1/13/2014
BrainStorm Cell Therapeutics Inc. Receives United States Patent Office Notice Of Allowance For Its Stem Cell Technology 1/13/2014
Suven Life Sciences Ltd Three (3) Product Patents For Their Nces In Australia, Sri Lanka And South Korea 1/9/2014
Pluristem Therapeutics (PSTI) Receives Key Placental Cell Therapy Patent in Australia 1/8/2014
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance To Grant European Patent Covering Its Stem Cells For The Treatment Of CNS Diseases 1/8/2014
Veloxis Pharmaceuticals A/S (VELO) Receives Notice Of Allowance From U.S. Patent Office For Diurnal-Independent Administration Of Envarsus® 1/8/2014
Enzymotec Granted Patent For A Lipid Preparation Use Method 1/6/2014
Actavis (ACT) Confirms Generic NuvaRing® Patent Challenge 12/27/2013
Caris Life Sciences Receives Patent For Molecular Profiling Service In The People's Republic Of China 12/17/2013
Scancell's DNA ImmunoBody® Patent Granted In Japan 12/12/2013
MorphoSys AG Strengthens European Patent Position On Anti-CD19 Cancer Program MOR208 12/3/2013
Amarin Corporation PLC (AMRN) Announces Notification Of Patent Allowances For U.S. Applications 13/685,281, And 13/685,291 Related To Triglyceride Lowering With A Mixture Of Omega-3 Free Fatty Acid (Including EPA And/Or DHA) In Both The MARINE And ANCHOR Patient Populations 12/2/2013
TopoTarget A/S Release: Allowance Of Key Belinostat Patent In Europe 11/21/2013
Plasticell Release: Additional Family Of CombiCult® Patents Granted In USA, Europe, Australia And Singapore 11/18/2013
BioAlliance Pharma Strengthens Sitavig Patent Protection With New U.S. And South Korean Issued Patents 11/14/2013
Zysis Receives U.S. Patent for Long Acting Oral Aripiprazole Once Weekly 11/13/2013
Can-Fite BioPharma (CFBI) Release: U.S. Patent and Trademark Office Grants a Patent for the Reduction of Intraocular Pressure 11/6/2013
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their NCEs in U.S.A. and Japan 11/6/2013
Enzymotec Granted Patent for Its Composition of Vayacog® Addressing Memory and Mild Cognitive Impairment 10/30/2013
Drawbridge Pharmaceuticals Granted New Anaesthesia Patents for Phaxan™ 10/28/2013
Immunicum's Patent Application Regarding the Company’s Core-Technology for Therapeutic Cancer Vaccination Using Allogeneic Dendritic Cells is Being Approved in the U.S. 10/25/2013
Merus Granted European Patent on MeMo®, a Transgenic Mouse for Generating the Building Blocks of Therapeutic Human Bispecific Antibodies 10/23/2013
Mystic Pharmaceuticals Receives Notices of Allowance From Japan and China on Drug Delivery Platform Technologies 10/1/2013
Suven Life Sciences Ltd Secures Three (3) Product Patents for Their New Chemical Entities, Inc.'s in New Zealand, Singapore and South Korea 9/25/2013
Mylan Inc. (MYL) Will Not Shy Away From Pursuing "Frivolous" Patents 9/12/2013
Pluristem Therapeutics (PSTI) Granted Key U.S. Patent for the Treatment of Peripheral Artery Disease 9/11/2013
Roche (RHHBY) Gives Up on India Patent for Breast Cancer Drug 8/16/2013
Suven Life Sciences Ltd Secures Two (2) Product Patents for Their New Chemical Entities, Inc.'s in Europe 8/8/2013
Roche (RHHBY) Cancer Drug Suffers Patent Setback in India 8/6/2013
China's SIPO Voids Patent for Gilead Sciences, Inc. (GILD)'s Viread 7/30/2013
Indian Ministry Wants to Cancel Patent on Roche (RHHBY) Cancer Drug 7/26/2013
Riboxx Announces RNA Manufacturing Patent Grant by EPO 7/17/2013
Genetic Technologies Limited (GTG.AX) Announces U.S. Patent Office Allows First Patent for ImmunAid 7/10/2013
Suven Life Sciences Ltd Secures Two Product Patents for Their NCEs in Japan and U.S.A. 6/28/2013
As Field Hots Up, Virttu Biologics Secures U.S. Patent Allowance on Next-Generation Oncolytic Virus Candidates Engineered to Express Antisense Sequences 6/25/2013
Kamada Ltd. (KMDA.TA) Granted Two Key Patents 6/24/2013
Anergis Files Provisional U.S. Patent on AllerDM Dust Mite Allergy Treatment 6/13/2013
QRxPharma Pty Ltd. Granted US Patent on Hybrid Opioids 6/12/2013
Patrys Limited (PAB.AX) Granted Key Patent for Lead Product – PAT-LM1 6/7/2013
Verva Pharmaceuticals Announces Grant of United States Patent for Type 2 Diabetes Therapy VVP808 and Results of Annual General Meeting 6/3/2013
Ockham Overturns Vectura Group plc (VEC.L)'s Challenge to Secure European Patent Rights for Inhaled Heparin in the Treatment of COPD 6/3/2013
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa® and Statin Therapy 5/22/2013
New Japanese Protozoal Patent for BioDiem Ltd. (BDM.AX)'s BDM-I 5/22/2013
European and U.S. Cellulase Patents Granted to DIREVO Industrial Biotechnology GmbH 5/21/2013
Biotage AB (BIOTa.ST) and Peptide Synthesis 5/13/2013
Suven Life Sciences Ltd Secures Three Product Patents for Their NCEs in Canada and Eurasia 5/10/2013
Novartis AG (NVS) Sees Boost From Program Designed to Speed Life-Saving Therapies 5/6/2013
Imugene Limited (IMU.AX) Granted Chinese Patent for Novel Drug Delivery Technology 4/30/2013
Teva Pharmaceutical Industries Limited (TEVA) Welcomes Landmark "Victory for Patient" in Intellectual Property Case 4/30/2013
GW Pharmaceuticals Announces U.S. Patent Allowance for SATIVEX® Formulation Spray Device 4/22/2013
ARTES Biotechnology Issued New Patent in Australia for VLP Technology 4/22/2013
Addex Therapeutics (ADXN.SW) Announces Issuance of a Broad European Composition of Matter Patent for Dipraglurant 4/22/2013
Medgenics, Inc. Receives Notice of Allowance From the U.S. Patent Office for Claims That Expand IP for Its Platform Technology to Additional Therapeutic Proteins 4/22/2013
Starpharma Holdings Ltd Granted New Drug Delivery Patents 4/17/2013
Suven Life Sciences Ltd Secures 4 Product Patents for Their NCEs in China, Mexico and New Zealand 4/17/2013
Prima Biomed (PRR.AX) Awarded Japanese Patent for CVac™ 4/17/2013
Celsus Therapeutics Announces Notification of Patents Granted 4/17/2013
Glenmark Pharmaceuticals to Respond to Patent Row With Merck & Co., Inc. (MRK) Next Month 4/15/2013
AstraZeneca PLC (AZN) Suffers Fresh Drug Patent Setback in U.S. 4/2/2013
Novartis AG (NVS) Loses Cancer Drug Glivec Patent Case 4/1/2013
European Patent Office to Grant Patent for Macrocure's CureXcell® 3/21/2013
Genetic Technologies Limited (GTG.AX) Provides U.S. Patent Re-Examination Update 3/15/2013